These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 3265291)

  • 1. [Functional interaction of dopamine receptors and chronic treatment with dopamine-antagonists].
    Barone P; Tucci I; Parashos SA
    Ann Ist Super Sanita; 1988; 24(4):547-50. PubMed ID: 3265291
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioural differentiation between effects elicited at dopamine D-1 and D-2 receptors in rats.
    Arnt J; Hyttel J
    Clin Neuropharmacol; 1986; 9 Suppl 4():17-9. PubMed ID: 2952268
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional interactive effects of D1 and D2 dopamine receptor blockade.
    Salama AI; Saller CF
    Adv Exp Med Biol; 1986; 204():137-50. PubMed ID: 2947425
    [No Abstract]   [Full Text] [Related]  

  • 4. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
    Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of [3H]nicotine binding in hypothalamic and cortical membranes by dopamine D1 receptors.
    Fuxe K; von Euler G; Finnman UB; Agnati LF
    Acta Physiol Scand; 1989 Jun; 136(2):295-6. PubMed ID: 2528887
    [No Abstract]   [Full Text] [Related]  

  • 8. Conformational analysis and structure-activity relationships of selective dopamine D-1 receptor agonists and antagonists of the benzazepine series.
    Pettersson I; Liljefors T; Bøgesø K
    J Med Chem; 1990 Aug; 33(8):2197-204. PubMed ID: 1973733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anorectic effect of SK & F 38393, a new dopamine agonist in rats.
    Girdhar A; Sharma DC; Sachdev KS
    Indian J Physiol Pharmacol; 1982; 26(4):317-20. PubMed ID: 6984016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An iodinated ligand identifying the D-1 dopamine receptor.
    Sidhu A; Kebabian JW
    Eur J Pharmacol; 1985 Jul; 113(3):437-40. PubMed ID: 2931288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D1 and D2 dopamine receptors and the regulation of striatal acetylcholine release in vivo.
    Consolo S; Girotti P; Zambelli M; Russi G; Benzi M; Bertorelli R
    Prog Brain Res; 1993; 98():201-7. PubMed ID: 7902591
    [No Abstract]   [Full Text] [Related]  

  • 12. [Differential regulation of dopamine receptors on pre- and postsynaptic Na+, K(+)-ATPase in rat striatum].
    Hu G; Qin W
    Yao Xue Xue Bao; 1997 Apr; 32(4):241-4. PubMed ID: 11499023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
    Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, resolution, and preliminary evaluation of trans-2-amino-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes and related derivatives as dopamine receptors ligands.
    Claudi F; Cingolani GM; Di Stefano A; Giorgioni G; Amenta F; Barili P; Ferrari F; Giuliani D
    J Med Chem; 1996 Oct; 39(21):4238-46. PubMed ID: 8863801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased motor activity following combined stimulation of B-HT 920-sensitive and D-1 dopamine receptors.
    Andén NE; Grabowska-Andén M
    Acta Physiol Scand; 1987 Sep; 131(1):157-8. PubMed ID: 2890261
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
    Ralph RJ; Caine SB
    J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of GABA release by dopamine in the substantia nigra.
    Matuszewich L; Yamamoto BK
    Synapse; 1999 Apr; 32(1):29-36. PubMed ID: 10188635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dopaminergic agonists and antagonists on the partially contracted, isolated and perfused renal artery of the rat.
    Rodriguez-Mendez SA; Feria M; Boada J
    Pharmacology; 1986; 32(6):321-5. PubMed ID: 3487804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dopamine receptors in the ventral tegmental area in conditioned fear.
    de Oliveira AR; Reimer AE; Brandão ML
    Behav Brain Res; 2009 May; 199(2):271-7. PubMed ID: 19111792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of the D-1 dopamine receptor in the substantia nigra of several mammalian species: identification in binding studies using [125I]SCH 23982.
    Yamamoto T; Kebabian JW
    Brain Res; 1987 Mar; 407(2):398-400. PubMed ID: 3032368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.